Current research does not establish what many years of repeated masseter treatment do to the jaw. A 2024 review reported a pooled reduction in mandibular cortical thickness, while 2025 density and 2026 morphology analyses from the same randomised trial found no clinically significant density change or detectable predefined shape change over one year. Those findings address different measurements, not the cumulative effect of many cycles.
The useful answer is bounded, not alarming
Research over one year answers some specific questions about jaw measurements. It does not establish what many treatment cycles over several years may mean for the jaw, muscle bulk or lower-face balance.
That uncertainty is a reason for thoughtful review, not alarm. If you are considering whether to continue, bring your treatment history and the changes you have noticed. Corey can assess the lower face in context and help you decide whether to wait, seek another opinion or discuss a suitable next step.
Three checks make the evidence easier to use
One year is not long term
The later trial papers followed one or two sessions over twelve months. They cannot answer what happens after many cycles over several years.
Endpoints are not interchangeable
Cortical thickness, CT density and morphology describe different features. A stable result in one does not settle the others.
Two papers, one trial
The 2025 and 2026 analyses add different information, but both come from NCT02010775 rather than separate replications.
What this means for your next decision
You do not need to interpret every scan measurement before booking a conversation. The useful starting point is your own history: how many previous cycles you have had, what changed, whether you liked the balance of your lower face and whether any jaw symptoms are present.
Corey Anderson RN stays with the decision from assessment through any later review. He considers whether the masseter is contributing to the concern, whether its existing bulk is supporting the lower face and whether cosmetic planning should continue at all.
Dental pain, clicking, restricted movement or functional symptoms may need dental or medical assessment. If those are not the issue, a consultation can still be used for information and questions without assuming treatment will follow.
What has the research actually measured?
The publications do not all ask the same question. Keeping each endpoint beside its timeframe prevents a narrow result from becoming a broad promise.
Cortical thickness signal
The pooled human evidence reported a 6.34% reduction in mandibular cortical thickness. The studies were small and varied, so this is not a prediction for an individual face.
CT density over one year
A prespecified subgroup showed no clinically significant density change against baseline or placebo after one or two sessions.
Predefined morphology measures
The broader population showed no detectable difference from placebo in predefined shape and insertion-site measures over one year.
Thickness, density and shape are not the same
Cortical thickness describes the width of the hard outer shell of bone. Density describes how compact a measured region appears on CT. Morphology describes dimensions, angles and overall shape.
One endpoint can remain stable while another changes. The 2025 density result does not erase the thickness signal reported in the 2024 review, and that pooled thickness signal does not prove a visible facial change.
This distinction is central to the long-term question. It lets you read a reassuring result within its proper limits without turning uncertainty into a prediction of harm.
One year cannot answer the many-cycle question
The later papers are reassuring for the people, exposure, measurements and twelve-month window studied. They do not establish the cumulative effect of repeated treatment over several years. See how Core Aesthetics reads timeframe and endpoint limits.
Bring your history to a calm assessment
Meet directly with Corey in Oakleigh to connect the evidence with your own treatment history, lower-face balance and questions about continuing or waiting.
Corey looks at the masseter in lower-face context, explains what the research can and cannot answer, and discusses costs only if a cosmetic pathway is appropriate to explore. The visit may lead to waiting, referral or no treatment.
Evidence at a glance
Each finding only applies to the population, exposure, endpoint and timeframe that produced it.
| Publication | What it measured | Finding within scope | Important limit |
|---|---|---|---|
| 2024 systematic review and meta analysis | Mandibular cortical thickness | Pooled reduction of 6.34%. The condyle estimate was larger. | Small, varied human studies. The condyle estimate came from two studies. |
| 2025 randomised trial analysis | CT density at the condyle, premolar area and ramus | No clinically significant change against baseline or placebo. | Prespecified subgroup of 123 adults, one or two sessions over twelve months. CT Hounsfield units are not absolute bone mineral density. |
| 2026 morphology analysis | Bigonial width, insertion-site thickness, flare and gonial angles, plus qualitative joint measures | No detectable difference from placebo in predefined measures. | 187 adults from the same trial, one or two sessions over twelve months. Not an independent replication. |
Lower-face hollowing deserves its own question
The masseter contributes fullness around the jaw angle, so reduced muscle bulk can change lower-face balance without proving that bone has changed. Weight change, cheek support, natural anatomy and the amount of muscle reduction can also affect what you see.
If your lower face looks flatter, narrower or more hollow than you intended, show Corey when you first noticed it and how it has changed. Assessment can help separate a visible concern from assumptions about its cause before any further decision is made.
What repeated treatment means in practice
A one-year study of one or two sessions cannot describe the effect of many cycles over several years. Your cumulative history therefore matters more than a generic maintenance schedule.
Before another decision, Corey reviews the number and timing of previous cycles, how fully the muscle and lower-face balance changed, and whether existing muscle bulk is now providing useful support. Waiting, referral or no treatment can be appropriate outcomes.
Risks to discuss before another decision
Potential risks include bruising, pain, temporary chewing weakness, altered smile movement, asymmetry and more lower-face hollowing than intended. Your discussion should reflect your anatomy, previous response, health history and any plan being considered.
Dental pain, jaw clicking, restricted movement or other functional symptoms may need dental or medical assessment rather than a cosmetic pathway. These symptoms should not be treated as an appearance-only question.
Funding context belongs beside the finding
The 2025 density and 2026 morphology papers report manufacturer sponsorship and author financial relationships. This does not make the findings false, but it supports the need for independent replication with longer follow-up and repeated exposure. The editorial and evidence policy describes how Core Aesthetics records funding and limitations.
How this evidence brief was built
This is a structured clinic evidence brief, not a formal systematic review or clinical practice guideline. The review used the recent human synthesis, the later randomised trial publications, the registered trial record and current Australian regulatory guidance.
Each paper was checked for population, exposure, comparator, endpoint, timeframe, funding and stated limitations. A finding is only applied to what the research measured. Where the evidence does not answer repeated exposure over several years, the brief keeps that gap visible.
What would make the long-term answer clearer?
Confidence would improve with independent prospective studies designed around cumulative exposure rather than a single year.
Several years and multiple cycles
Researchers need to record total exposure and follow participants beyond the current twelve-month window.
Validated endpoints
Thickness, density, morphology, muscle bulk and visible change should be reported separately with prespecified methods.
New groups and transparent reporting
Independent teams should publish funding, loss to follow-up and results that can be compared across studies.
Evidence brief revision history
| Date | Change | Reason |
|---|---|---|
| 3 August 2026 | Reordered the brief around common decision questions, paired evidence with consultation guidance and clarified the one-year evidence boundary. | Made the research scope and practical next steps easier to follow without changing the clinical conclusion. |
| 13 July 2026 | Separated the 2025 density paper from the 2026 morphology paper, corrected both DOI records, identified their shared trial and added funding disclosures. | The earlier version attached the morphology DOI to the density finding and did not make the shared trial clear. |
| 9 July 2026 | First clinic review published. | Created a patient-facing summary of long-term masseter questions. |
Choose the next page that matches your question
For the review method, read how to read a Core Aesthetics evidence brief. For anatomy, continue to masseter muscle explained. For individual plan variables, use jaw muscle assessment planning. If your question is about visiting the clinic rather than research, see jaw muscle consultations in Melbourne.
Bring the evidence question that matters to you
Meet Corey in Oakleigh to review your history, lower-face balance and whether continuing, waiting or another pathway makes the most sense.
General information and review scope
This page provides general information for adults considering consultation. It is not personal medical advice, a diagnosis, a formal systematic review or confirmation that treatment is suitable. The clinical evidence was reviewed by Corey Anderson RN on 13 July 2026, and the patient journey was editorially updated on 3 August 2026. Individual advice requires assessment by an appropriately qualified health practitioner.
Frequently Asked Questions
Can masseter treatment permanently change my face shape?
Treatment reduces masseter muscle bulk, which can change fullness and support in the lower cheek and jaw area. If treatment is discontinued, the muscle typically returns toward its previous size over about six to twelve months, but response varies and return can be incomplete after repeated cycles. Research has reported some jaw bone measurements changing, while other measurements remained unchanged over one year. Evidence about many cycles over several years is not yet conclusive.
Does masseter treatment cause a hollow face?
Some people describe a hollow, flat or gaunt lower face after extensive reduction because the masseter contributes to fullness around the jaw angle. This appearance does not prove bone loss. Facial structure, cheek support, weight change and the amount of muscle reduction can all affect how the lower face looks. Corey considers whether existing masseter bulk is contributing usefully before recommending further treatment.
Is masseter treatment reversible?
Muscle activity returns as the effect wears off, and the masseter usually returns toward its previous size over roughly six to twelve months after treatment stops. Individual response varies. Return can take longer or remain incomplete after repeated cycles. That muscle response is separate from the still uncertain question of whether many years of reduced loading can affect the jaw bone.
What is the difference between cortical thickness and bone density?
Cortical thickness describes the width of the hard outer shell of bone. Density describes how compact the measured bone appears. Morphology describes shape and dimensions. These endpoints are related but not interchangeable, so an unchanged density result does not by itself prove that thickness or shape cannot change.
Do the 2025 and 2026 papers independently confirm each other?
No. They are separate analyses and publications from the same underlying randomised trial, NCT02010775. The 2025 paper examined density in a prespecified subgroup, while the 2026 paper examined predefined shape and thickness measures in the broader trial population. They add useful endpoint information, but they are not independent replication in a second group of patients.
Why does repeated treatment matter more than one or two sessions?
A one year study of one or two sessions can only describe that exposure and timeframe. It cannot establish what happens after many cycles over several years. Cumulative dose, treatment interval, changing facial structure and incomplete return of muscle bulk may all matter, which is why ongoing review is more appropriate than automatic maintenance.
Were the later masseter studies manufacturer funded?
Yes. The 2025 density paper and 2026 morphology paper report manufacturer sponsorship and disclose author employment, consultancy or grant relationships. Funding does not make a study invalid, but it is relevant context when judging design, endpoint choices, interpretation and the need for independent replication.
Who might be advised not to continue masseter treatment?
Further treatment may not be appropriate when the lower face is already narrow, the masseter is contributing useful support, the concern is mainly structural or dental, or the likely benefit does not justify additional reduction. A consultation may end with waiting, referral or no treatment. Treatment is never automatic after booking.
Sources And Clinical References
- Ahpra guidelines for registered health practitioners who perform non surgical cosmetic procedures
- TGA guidance for advertising health services involving therapeutic goods
- Journal of Oral Rehabilitation, 2024, doi:10.1111/joor.13590
- Aesthetic Surgery Journal, 2025, doi:10.1093/asj/sjaf167
- Aesthetic Surgery Journal, 2026, doi:10.1093/asj/sjag080
- Clinical trial record NCT02010775
Is this for you?
Consider booking a consultation if
- Adults researching repeated masseter treatment, lower face hollowing or jaw bone questions
- People comparing cortical thickness, density and morphology findings
- People deciding whether another treatment cycle still suits their lower face
- People who want uncertainty, study funding and timeframe limits stated clearly
This may not be for you if
- People seeking diagnosis for jaw pain, clicking, restricted movement or dental symptoms
- People who want an article to determine personal suitability
- People expecting treatment to be automatic after booking
- People seeking a fixed prediction about long term facial change
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.